生物活性 | |||
---|---|---|---|
描述 | DTP3 acts as a powerful, selective inhibitor of GADD45β/MKK7. It is designed to engage a critical, cancer-specific survival mechanism that operates downstream from the NF-κB signaling pathway[1]. Administering DTP3 at a concentration of 10 μM for a duration ranging from 1 to 21 days leads to a robust and selective triggering of JNK activation and cell death via apoptosis. This is evidenced by the detection of phosphorylated JNK within 24 hours of treatment[2]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.90mL 0.38mL 0.19mL |
9.51mL 1.90mL 0.95mL |
19.03mL 3.81mL 1.90mL |
参考文献 |
---|